Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors (Q39325094)

11 September 2017

title

Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors (English)

1 reference

11 September 2017

0 references

Annabelle L Fonseca

1

1 reference

11 September 2017

Johan Kugelberg

2

1 reference

11 September 2017

Lee F Starker

3

1 reference

11 September 2017

Ute Scholl

4

1 reference

11 September 2017

Murim Choi

5

1 reference

11 September 2017

Per Hellman

6

1 reference

11 September 2017

Göran Åkerström

7

1 reference

11 September 2017

Gunnar Westin

8

1 reference

11 September 2017

Richard P Lifton

9

1 reference

11 September 2017

Peyman Björklund

10

1 reference

11 September 2017

Tobias Carling

11

1 reference

11 September 2017

publication date

26 June 2012

1 reference

Genes, Chromosomes and Cancer

11 September 2017

published in

1 reference

11 September 2017

volume

51

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

949-960

1 reference

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.

11 September 2017

cites work

1 reference

Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer

21 January 2018

1 reference

A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas

21 January 2018

1 reference

Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer

21 January 2018

1 reference

GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer

21 January 2018

1 reference

Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas

21 January 2018

1 reference

Pathogenesis of adrenocortical cancer

21 January 2018

1 reference

High-throughput DNA methylation profiling using universal bead arrays

21 January 2018

1 reference

Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia

21 January 2018

1 reference

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

21 January 2018

1 reference

Histone modifications silence the GATA transcription factor genes in ovarian cancer

21 January 2018

1 reference

BRCA1 methylation: a significant role in tumour development?

21 January 2018

1 reference

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension

21 January 2018

1 reference

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis

21 January 2018

1 reference

Methylation mediated silencing of TMS1/ASC gene in prostate cancer

21 January 2018

1 reference

Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer

21 January 2018

1 reference

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis

21 January 2018

1 reference

Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors

21 January 2018

1 reference

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

21 January 2018

1 reference

ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma

21 January 2018

1 reference

Hypermethylation of the GATA genes in lung cancer

21 January 2018

1 reference

Hypermethylation of the GATA gene family in esophageal cancer

21 January 2018

1 reference

Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.

21 January 2018

1 reference

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer

21 January 2018

1 reference

A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells

21 January 2018

1 reference

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group

21 January 2018

1 reference

The epigenomics of cancer

21 January 2018

1 reference

Cancer epigenetics comes of age

21 January 2018

1 reference

Differential expression and action of Toll-like receptors in human adrenocortical cells

21 January 2018

1 reference

Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome

21 January 2018

1 reference

Genotyping of Adrenocortical Tumors: Very Frequent Deletions of the MEN1 Locus in 11q13 and of a 1-Centimorgan Region in 2p16

21 January 2018

1 reference

HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells

21 January 2018

1 reference

Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.

21 January 2018

1 reference

Adrenocortical cancer: pathophysiology and clinical management

21 January 2018

1 reference

Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome

21 January 2018

1 reference

Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme

21 January 2018

1 reference

TMS1/ASC: the cancer connection

21 January 2018

1 reference

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample

21 January 2018

1 reference

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

21 January 2018

1 reference

HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients

21 January 2018

1 reference

Promoter CpG island hypermethylation during breast cancer progression.

21 January 2018

1 reference

Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?

21 January 2018

1 reference

The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.

21 January 2018

1 reference

Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

21 January 2018

1 reference

Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.

21 January 2018

1 reference

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies

21 January 2018

1 reference

Mutation and methylation analysis of TP53 in adrenal carcinogenesis.

21 January 2018

1 reference

Molecular markers and the pathogenesis of adrenocortical cancer

21 January 2018

1 reference

The DNA methylome of benign and malignant parathyroid tumors

21 January 2018

1 reference

Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma

21 January 2018

1 reference

Methylation profile in benign, borderline and malignant ovarian tumors.

21 January 2018

1 reference

Epigenetic inactivation of TMS1/ASC in ovarian cancer

21 January 2018

1 reference

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer

21 January 2018

1 reference

21 January 2018

Adrenocortical cancer

1 reference

21 January 2018

To infinium, and beyond!

1 reference

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets

21 January 2018

1 reference

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

21 January 2018

1 reference

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

21 January 2018

1 reference

P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.

21 January 2018

1 reference

21 January 2018

Weiss System Revisited

1 reference

Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype

21 January 2018

1 reference

7 January 2021

Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors

1 reference

7 January 2021

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

1 reference

7 January 2021

DNA methylation and cancer

1 reference

7 January 2021

Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy

1 reference

7 January 2021

Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival

1 reference

7 January 2021

DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder

1 reference

7 January 2021

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors

1 reference

7 January 2021

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors

1 reference

7 January 2021

Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.21978

1 reference

11 September 2017

1 reference